AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 287: H1214-H1224, 2004. First published May 13, 2004; doi:10.1152/ajpheart.00840.2003
0363-6135/04 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/3/H1214    most recent
00840.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Calbet, J. A. L.
Right arrow Articles by Wagner, P. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Calbet, J. A. L.
Right arrow Articles by Wagner, P. D.

Plasma volume expansion does not increase maximal cardiac output or VO2 max in lowlanders acclimatized to altitude

José A. L. Calbet,1,2 Göran Rådegran,2 Robert Boushel,2,4 Hans Søndergaard,2 Bengt Saltin,2 and Peter D. Wagner3

1Department of Physical Education, University of Las Palmas de Gran Canaria, 35010 Canary Islands, Spain; 2The Copenhagen Muscle Research Centre, Rigshospitalet, 2200 Copenhagen N, Denmark; 3Department of Medicine, Section of Physiology, University of California San Diego, La Jolla, California 92093; and 4Department of Exercise Science, Concordia University, Montreal, Quebec H4B 1R6, Canada

Submitted 2 September 2003 ; accepted in final form 28 April 2004


    ABSTRACT
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
With altitude acclimatization, blood hemoglobin concentration increases while plasma volume (PV) and maximal cardiac output (max) decrease. This investigation aimed to determine whether reduction of max at altitude is due to low circulating blood volume (BV). Eight Danish lowlanders (3 females, 5 males: age 24.0 ± 0.6 yr; mean ± SE) performed submaximal and maximal exercise on a cycle ergometer after 9 wk at 5,260 m altitude (Mt. Chacaltaya, Bolivia). This was done first with BV resulting from acclimatization (BV = 5.40 ± 0.39 liters) and again 2–4 days later, 1 h after PV expansion with 1 liter of 6% dextran 70 (BV = 6.32 ± 0.34 liters). PV expansion had no effect on max, maximal O2 consumption (O2), and exercise capacity. Despite maximal systemic O2 transport being reduced 19% due to hemodilution after PV expansion, whole body O2 was maintained by greater systemic O2 extraction (P < 0.05). Leg blood flow was elevated (P < 0.05) in hypervolemic conditions, which compensated for hemodilution resulting in similar leg O2 delivery and leg O2 during exercise regardless of PV. Pulmonary ventilation, gas exchange, and acid-base balance were essentially unaffected by PV expansion. Sea level max and exercise capacity were restored with hyperoxia at altitude independently of BV. Low BV is not a primary cause for reduction of max at altitude when acclimatized. Furthermore, hemodilution caused by PV expansion at altitude is compensated for by increased systemic O2 extraction with similar peak muscular O2 delivery, such that maximal exercise capacity is unaffected.

hypoxia; exercise; hemodynamics; blood volume; maximal oxygen uptake


BECAUSE HEMOGLOBIN (Hb) saturation is, in general, maintained close to its maximum even at maximal exercise, maximal cardiac output (max) is the principal factor determining maximal O2 delivery and hence exercise capacity at sea level (14, 16, 20, 50). During exercise at altitude, arterial O2 saturation (SaO2) falls as exercise intensity increases, and thus cardiac output () is even more critical to assure appropriate O2 delivery. Paradoxically, after a few weeks of residence at altitudes higher than 3,000 m, max is reduced by 4–7 l/min (8, 10, 36, 37). It was thought that the reduction of maximal heart rate with chronic hypoxia was the primary cause (36); however, we have recently shown otherwise, since restoring sea level maximal heart rate at altitude with parasympathetic blockade does not enhance max at altitude (8).

Acclimatization to high altitude entails both a reduction in plasma volume (PV) and a slow increase in red cell mass; consequently, blood volume (BV) remains below sea level values during the first 2–4 mo at altitude (2, 35, 38). Hypovolemia, through its effects on preload, has been proposed as a factor contributing to the reduction of max in chronic hypoxia (1, 2, 37, 48). Experimental evidence for this is, however, not convincing. If the reduction in max is caused by lowered BV, PV expansion should increase max during exercise at altitude and therefore improve maximal O2 uptake (O2 max) and exercise performance (5, 15, 42).

Accordingly, the aim of this study was to determine whether max can be increased with PV expansion in a group of well-acclimatized lowlanders after 9 wk at an altitude of 5,260 m. Additionally, we assessed the impact of PV expansion on exercise capacity, O2 transport and utilization, gas exchange, and acid-base status during maximal exercise.


    METHODS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Subjects. Eight healthy Danish lowlanders (3 women and 5 men) volunteered to participate in these studies. Their mean (±SE) age, height, and weight were 24.0 ± 0.6 yr, 177 ± 3 cm, and 76 ± 4 kg, respectively. All subjects were physically active but none were engaged in regular training. Their main physical activity was biking to move around Copenhagen, and occasionally they participated in recreational sport activities. The subjects were informed about the procedures and risks of the study before giving written informed consent to participate as approved by the Ethical Committee of Copenhagen-Fredriksberg. Euvolemic data from these subjects have been previously reported (13) and are used here as control to the hypervolemic condition.

Experimental design. As part of preliminary examinations, ~2 mo before altitude exposure, subjects performed an incremental exercise test to exhaustion on a cycle ergometer. O2 max averaged 56 ± 2 ml·kg–1·min–1 breathing air at sea level, and peak power output was 300 ± 17 W. This O2 max is ~20% higher than reported for the general Danish population of similar age (3) but 20–30% lower than observed in elite endurance athletes.

The present study was conducted at altitude after 9 wk of residence at 5,260 m at Mt. Chacaltaya, Bolivia. During this period, subjects undertook two brief (2–3 days) climbs of neighboring 6,000-m peaks (1 in wk 2 and 1 in wk 7) and a 1-day recreational bicycle descent to 2,000 m (in wk 6). Otherwise, they all remained at Mt. Chacaltaya, where they spent part of the day hiking around the facilities. Subjects performed submaximal and maximal upright cycling exercise at two different levels of BV. The first was at the BV attained after acclimatization {referred to as the euvolemic condition; Hb concentration ([Hb]) = 185 ± 5 g/l, hematocrit = 52 ± 1%, and BV = 5.40 ± 0.39 liters}. Between 2 and 4 days later, the same exercise protocol was repeated 30 min after hypervolemic hemodilution ([Hb] = 150 ± 5 g/l, hematocrit = 41 ± 1%, and BV = 6.32 ± 0.34 liters). Two experiments with the same exercise protocol were carried out on the second experimental day. First, subjects underwent isovolemic hemodilution by replacement of 1 liter of blood with 1 liter of 6% dextran 70 solution (Macrodex, Pharmalink) (13). At the end of exercise with isovolemic hemodilution, subjects rested for at least 90 min. During the resting period, the blood withdrawn was reinfused to create the hypervolemic condition while the subjects had some food and drinks.

Experimental preparation. After administration of local anesthesia, we inserted Teflon catheters in the femoral artery and vein for blood sampling and for the determination of leg blood flow with the thermodilution technique (4). An additional catheter was placed in a vein in the left forearm for the injection of indocyanine green to measure . After catheterization, the subjects rested in the supine position for 30 min before the exercise test.

Exercise protocol. Two exercise levels were undertaken: submaximal (120 W) and maximal exercise, both on a Monark cycle ergometer. Thirty minutes after catheterization, subjects sat on the cycle ergometer and breathed room air [408 mmHg, inspired PO2 (PIO2) = 75–76 mmHg] for 5 min before resting measurements were made (Fig. 1). Subjects then cycled at 120 ± 4 W, which was the highest intensity they could tolerate for 10 min when exercising in acute hypoxia (11). Measurements were made at 6 and 10 min. Subsequently, after rest for ~10 min, the maximal exercise test was started with 2 min at the intensity used earlier in the submaximal test. Exercise intensity was then increased rapidly to 90% of previously determined peak levels (maximal power output; max). After 2 min, measurements were made and the load was increased as tolerated to maximal levels by ~20–40 W every minute until reaching the maximal exercise intensity. After ~1 min at the maximal load, measurements were repeated. Then, if subjects were not exhausted, the load was increased by 20 W and measurements were repeated after 1 min and so on until the subjects were almost exhausted. Still cycling at this workload, subjects were switched to 55% O2 in nitrogen (PIO2 of ~200 mmHg), and, after 2 min at this PIO2, a further set of measurements was made. Finally, the workload was increased as tolerated at a rate of 20 W/min to a new maximal value, with measurements repeated.



View larger version (13K):
[in this window]
[in a new window]
 
Fig. 1. Experimental protocol. Vertical arrows indicate the time points at which measurements were performed.

 
Measurements. BV was determined with indocyanine green (Akorn) while the subjects rested quietly in the supine position (21). Pulmonary O2 consumption (O2), CO2 production (CO2), and expired minute ventilation (E) were measured continuously with an online system (Medical Graphics CPX, Minneapolis, MN) and averaged every 15 s. During the incremental exercise, the highest O2 value recorded during any single 15-s interval was taken as the O2 max. At peak effort, the measurements were made when the O2 had plateaued and the subjects were close to exhaustion. Femoral venous blood flow (i.e., leg blood flow; LBF) was measured in the femoral vein by constant-infusion thermodilution as described in detail elsewhere (4). Arterial blood pressure was monitored continuously by a disposable transducer (model T100209A, Baxter). The blood pressure transducer and the electrocardiogram electrodes were interfaced with a monitor, which was in turn connected to the data acquisition system. was measured with the dye-dilution method with the use of indocyanine green as previously reported (8, 10, 11, 13, 20, 39). Blood [Hb] and O2 saturation (SO2) were measured with a cooximeter (OSM 3 Hemoximeter, Radiometer). PO2, PCO2, and pH were determined with a blood gas analyzer (ABL 5, Radiometer) and corrected for measured femoral vein blood temperature (45). Hematocrit was determined by microcentrifugation on triplicate samples. Plasma K+ concentration was measured with an electrolyte metabolite analyzer (EML 105, Radiometer). Plasma norepinephrine and epinephrine concentrations were measured by HPLC with electrochemical detection (22).

Calculations. Arteriovenous O2 concentration difference [(a-v)O2] was calculated from the difference in femoral arterial and femoral venous O2 concentrations. This difference was then divided by arterial concentration to give O2 extraction. O2 delivery was computed as the product of blood flow and CaO2. Leg O2 was calculated as the product of LBF and the (a-v)O2. Non-LBF was computed as the difference between and 2-leg blood flow (2-LBF). Mean blood pressure was obtained by integrating the blood pressure curve over time. Systemic and leg vascular conductances were calculated as blood flow (either LBF or ) divided by mean arterial pressure.

Statistical analysis. Differences in the measured variables among conditions and exercise levels were analyzed with two-way ANOVA for repeated measures, with [Hb] and exercise intensity as within-subjects factors. Two separated ANOVA analyses were performed: one for the part of the experiment where subjects breathed room air and another for the exercise with hyperoxic breathing. When F was significant in the ANOVA, planned pairwise specific comparisons were carried out using Student's paired t-test adjusted for multiple comparisons with the Bonferroni procedure. The influence of hyperoxia on variables measured at maximal exercise was tested by use of the Student's paired t-test. Comparisons between maximal exercise in normoxia (sea level control experiments) and chronic hypoxia were also performed using the Student's paired t-test. In addition, the mean blood flow response during the euvolemic conditions was compared with the mean LBF observed during the hypervolemic conditions, also by use of a Student's paired t-test. Simple linear regression analysis was performed to determine linear relations between variables. Significance was accepted at P < 0.05. Data are reported as means ± SE.


    RESULTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Exercise capacity and O2. Breathing ambient air at maximal exercise, subjects showed no significant differences in maximal pulmonary or leg O2 or in power output comparing euvolemic and hypervolemic conditions (Fig. 2, A and B). When 55% O2 was breathed, maximal power output and leg O2 were increased, attaining exhaustion values similar to those observed at sea level.



View larger version (15K):
[in this window]
[in a new window]
 
Fig. 2. Pulmonary O2 uptake (O2) (A) and 2-leg O2 (B) during submaximal and maximal exercise, with the blood volume (BV) attained after 9 wk of residence at an altitude of 5,260 m or euvolemia and after hypervolemic hemodilution. Exercises performed while room air was breathed at altitude (hypoxia) are represented by solid symbols. Hyperoxic conditions at altitude [inspired O2 fraction (FIO2) = 0.55] are represented by open symbols. Because of technical constraints, pulmonary O2 was not measured during hyperoxia at altitude; instead, the values observed during the sea level control experiments are plotted ({circ}). Sea level data were obtained in the same subjects using the same experimental protocol at least 6 mo after the return to sea level, as recently reported (12). §P < 0.05, comparison between hypoxia and hyperoxia at the same exercise intensity and Hb concentration ([Hb]); ¶P < 0.05, difference between maximal exercise in hypoxia and maximal exercise in hyperoxia at the same [Hb]; and ¥P < 0.05, compared with maximal exercise in normoxia at sea level.

 
Pulmonary ventilation and gas exchange. During submaximal exercise under conditions of breathing room air, a similar pulmonary ventilation, CO2, and ventilatory equivalents for O2 and CO2 (E/O2 and E/CO2, respectively) were observed before and after PV expansion (Fig. 3, AD). As depicted in Fig. 3E, alveolar PO2 (PAO2) was slightly higher during maximal exercise after PV expansion than before (61 ± 2 and 63 ± 1 mmHg, P < 0.05), likely linked to an increased pulmonary ventilation after PV expansion (162 ± 14 and 169 ± 15 l/min, P = 0.05). Before PV expansion, the alveolar-arterial PO2 gradient [(A-a)DO2] was 13.4 ± 0.6 and 15.8 ± 1.1 mmHg during submaximal and maximal exercise, respectively, and was increased to 14.8 ± 0.8 and 17.2 ± 0.9 mmHg after PV expansion (P < 0.05) (Fig. 3F). Pulmonary ventilation, CO2, E/O2, E/CO2, PAO2, and (A-a)DO2 increased with exercise intensity (P < 0.05).



View larger version (19K):
[in this window]
[in a new window]
 
Fig. 3. Pulmonary ventilation (E, A), CO2 production (CO2, B), ventilatory equivalents for O2 and CO2 (E/O2 (C), and E/CO2 (D), respectively), alveolar PO2 (PAO2 (E)), and alveolar-arterial PO2 gradient [(A-a)DO2] (F) during submaximal and maximal exercise, with the BV attained after 9 wk of residence at an altitude of 5,260 m or euvolemia and after hypervolemic hemodilution (PVE). Exercises performed while room air was breathed at altitude (hypoxia) are represented by solid symbols. Because of technical constraints, systemic O2 was not measured during hyperoxia at altitude; instead, the values observed during the sea level control experiments are plotted ({circ}). Sea level data were obtained in the same subjects using the same experimental protocol at least 6 mo after the return to sea level, as recently reported (12). *P < 0.05, comparison between euvolemia and PVE; and ¥P < 0.05, compared with maximal exercise in normoxia at sea level.

 
[Hb] and arterial and femoral venous blood gases. The 9 wk of exposure to altitude increased blood [Hb] by 36% compared with that at sea level (185 ± 4 vs. 136 ± 5 g/l, averaging arterial and venous data), whereas PV expansion caused a 19% drop in [Hb] due to hemodilution (Table 1). Arterial PO2 (PaO2), PCO2, and SO2 were all reduced as expected at altitude, but PV expansion had no significant effect on these variables at rest or at any exercise level (Table 1). O2 extraction, defined as (a-v)O2 divided by arterial O2 concentration, increased as a response to the reduction in [Hb] caused by the PV expansion (Fig. 4, A and B). Systemic O2 extraction increased with exercise intensity (P < 0.05). This increase was more accentuated after hemodilution than during the euvolemic condition, as indicated by the significant interaction in the ANOVA analysis.


View this table:
[in this window]
[in a new window]
 
Table 1. Femoral arterial and venous blood gases and acid-base balance

 


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 4. Systemic (Sys) (A) and leg O2 extraction (B) during submaximal and maximal exercise, with the BV attained after 9 wk of residence at an altitude of 5,260 m or euvolemia and after PVE. Exercises performed while room air was breathed at altitude (hypoxia) are represented by solid symbols. Hyperoxic conditions at altitude (FIO2 = 0.55) are represented by open symbols. Because of technical constraints, systemic O2 was not measured during hyperoxia at altitude; instead, the values observed during the sea level control experiments are plotted ({circ}). Sea level data were obtained in the same subjects using the same experimental protocol at least 6 mo after the return to sea level, as recently reported (12). *P < 0.05, comparison between euvolemia and PVE; ¶P < 0.05, difference between maximal exercise in hypoxia and maximal exercise in hyperoxia at the same [Hb]; and ¥P < 0.05, compared with maximal exercise in normoxia at sea level.

 
, LBF, and arterial O2 delivery. Resting was increased by 34% (P < 0.05) with PV expansion and heart rate by 35% (P < 0.05), which implies that, at rest, stroke volume was similar in both conditions. As previously reported, resting stroke volume at altitude was, however, 24% lower than at sea level (10). As illustrated in Figs. 5 and 6, , 2-LBF, systemic O2 delivery, leg O2 delivery, heart rate, and stroke volume increased with exercise intensity. There was a significant interaction in the response to exercise while the subjects breathed room air. At maximal exercise under conditions of breathing ambient air, was the same at both levels of BV (Fig. 5A). However, during submaximal exercise in the expanded volume condition, was elevated because of an enhancement of heart rate (Fig. 6A, P < 0.05), since the stroke volume response was not affected by PV expansion at any exercise intensity regardless of oxygenation status (Fig. 6B). In contrast, when all leg flow data were pooled together, LBF was higher during the volume-expanded condition at any work rate (Fig. 5B) (P = 0.05). During maximal exercise in chronic hypoxia, PV expansion resulted in ~10% higher "double product" (heart rate times systolic blood pressure) compared with the euvolemic condition (P < 0.05).



View larger version (25K):
[in this window]
[in a new window]
 
Fig. 5. Cardiac output () (A), 2-leg blood flow (2-LBF) (B), systemic O2 delivery (C), and 2-leg O2 delivery (D) during submaximal and maximal exercise, with the BV attained after 9 wk of residence at an altitude of 5,260 m or euvolemia and after PVE. Exercises performed while room air was breathed at altitude (hypoxia) are represented by solid symbols. Hyperoxic conditions at altitude (FIO2 = 0.55) are represented by open symbols. *P < 0.05, comparison between euvolemia and PVE; §P < 0.05, comparison between hypoxia and hyperoxia at the same exercise intensity and [Hb]; and ¶P < 0.05, difference between maximal exercise in hypoxia and maximal exercise in hyperoxia at the same [Hb].

 


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 6. Heart rate (A) and stroke volume (B) during submaximal and maximal exercise, with the BV attained after 9 wk of residence at an altitude of 5,260 m or euvolemia and after PVE. Exercises performed while room air was breathed at altitude (hypoxia) are represented by solid symbols. Hyperoxic conditions at altitude (FIO2 = 0.55) are represented by open symbols. §P < 0.05, comparison between hypoxia and hyperoxia at the same exercise intensity and [Hb]; and ¶P < 0.05, difference between maximal exercise in hypoxia and maximal exercise in hyperoxia at the same [Hb].

 
Systemic O2 delivery was reduced after PV expansion at all exercise intensities and inspired O2 fractions (FIO2) with the exception of submaximal exercise, for which similar values were observed at the two levels of volemia tested (Fig. 5C). Despite the lower CaO2 in the hypervolemic condition, leg O2 delivery was maintained because of the increase in LBF (Fig. 5D). Taken together with the above-mentioned increases in O2 extraction, these data account for the lack of effect of PV expansion on O2 at either whole body or leg level.

Distribution of . During maximal exercise, was unaffected by PV expansion, and a nonsignificant increase of peak LBF (P = 0.10) combined with a nonsignificant reduction of perfusion of the body [6.2 ± 0.2 l/min (euvolemia) vs. 4.6 ± 1.1 l/min (hypervolemia); P = 0.07] was observed. In addition, non-LBF during maximal exercise increased with hyperoxic breathing (ANOVA, P < 0.05). This effect was significant only in the euvolemic condition, where non-LBF increased from 6.2 ± 0.7 to 8.4 ± 1.1 min/l (P < 0.05), and non-LBF was similar during the hypervolemic condition (4.6 ± 1.1 to 6.0 ± 1.2 l/min, breathing room air and hyperoxia, respectively; P = 0.2). At maximal exercise with hyperoxia, non-LBF was greater in the euvolemic than in the hypervolemic condition (P < 0.05).

Mean arterial pressure, systemic vascular conductance, and leg vascular conductance. Vascular conductances increased with exercise intensity (P < 0.05). During submaximal and maximal exercise, mean arterial pressure and total systemic vascular conductance were similar regardless of BV and FIO2 (Figs. 7A and 4B). Leg vascular conductance, however, was increased by PV expansion (P < 0.05) (Fig. 7C).



View larger version (13K):
[in this window]
[in a new window]
 
Fig. 7. Mean arterial pressure (MAP, A), systemic vascular conductance (Sys VC, B) and 1-leg vascular conductance (LVC, C) during submaximal and maximal exercise, with the BV attained after 9 wk of residence at an altitude of 5,260 m or euvolemia and after hypervolemic hemodilution (PVE). Exercises performed while room air was breathed at altitude (hypoxia) are represented by solid symbols. Hyperoxic conditions at altitude (FIO2 = 0.55) are represented by open symbols. *P < 0.05, comparison between euvolemia and PVE; and ¶P < 0.05, difference between maximal exercise in hypoxia and maximal exercise in hyperoxia at the same [Hb].

 
Catecholamines. As depicted in Fig. 8, both catecholamines increased with exercise intensity (P < 0.05). PV expansion did not affect the arterial epinephrine and norepinephrine responses at any work rate or FIO2, but both hormones reached a higher concentration during maximal exercise with hyperoxia than at maximal exercise while breathing room air (Fig. 8) (P < 0.05). was closely related to the arterial epinephrine (r = 0.86, P < 0.01) and norepinephrine (r = 0.94, P < 0.01) concentrations across experimental conditions.



View larger version (16K):
[in this window]
[in a new window]
 
Fig. 8. Plasma catecholamine responses during submaximal and maximal exercise, with the BV attained after 9 wk of residence at an altitude of 5,260 m or euvolemia and after hypervolemic hemodilution (PVE). Exercises performed while room air was breathed at altitude (hypoxia) are represented by solid symbols. Hyperoxic conditions at altitude (FIO2 = 0.55) are represented by open symbols. NE, norepinephrine. ¶P < 0.05, difference between maximal exercise in hypoxia and maximal exercise in hyperoxia at the same [Hb].

 

    DISCUSSION
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
The main finding of this study is that expansion of PV with 1 liter of 6% dextran in humans well acclimatized to a very high altitude had no effect on max and O2 max. Thus this study does not support the hypothesis of Alexander et al. (2) that PV expansion immediately before exercise should enlarge max, O2, or maximal power output.

Effect of PV expansion on at rest and during submaximal exercise. The fact that our subjects remained active, hiking around the laboratory facilities and participating in two short expeditions (2–4 days) to peaks at 6,080 and 6,500 m, could have contributed to preserve exercise capacity and, perhaps, to mitigate the expected drop in PV with chronic hypoxia (44). However, compared with normoxic sea level values, resting stroke volume was markedly reduced after 9 wk at 5,260 m. The reduction in resting stroke volume at altitude is a well known phenomenon, which has been attributed to decreased preload in chronic hypoxia (1, 2, 37, 48). This explanation is supported by the observation of reductions in left ventricle end-diastolic diameter, cardiac filling pressures, and circulating BV after altitude acclimatization (1, 2, 37, 48). The BV after 9 wk at 5,260 m was 10–15% lower than expected for physically active subjects (29, 44, 51). Thus a lower circulating BV and hence preload could account for the reduced resting stroke volume after altitude acclimatization in our subjects. PV expansion effectively increased resting (+34%) (10) and submaximal exercise (+12%), meaning that venous return was elevated by PV expansion. For a fixed heart rate, inotropic state, and afterload, an increased venous return elicits an enhancement of stroke volume because of the recruitment of the Frank-Starling mechanism. In the present investigation, however, the enhancement of resting and submaximal was entirely achieved through the elevation of heart rate, perhaps facilitated by the so-called Bainbridge reflex (27). Parallel experiments performed during this expedition have demonstrated a paradoxical high activity of both the parasympathetic (8) and sympathetic (10, 23) branches of the autonomous nervous system at rest and during submaximal and maximal exercise as well. Given the fact that sympathetic activity was slightly decreased by PV expansion (23), it is likely that the mechanism accounting for the increase in resting and submaximal exercise heart rate involves an attenuation of parasympathetic activity.

Effect of PV expansion on max and O2 max. The absence of enhancement of max, despite a substantial increase of PV, suggests that the level of hemoconcentration existing after 9 wk at altitude has little if any influence on cardiac function during maximal exercise at altitude, as recently demonstrated (13). Like us, Alexander et al. (2) found greater values during submaximal exercise after PV expansion. However, the effect of PV expansion on stroke volume was not conclusive, since the increase in was brought about through an enhancement of heart rate in one subject, whereas the other subject increased the stroke volume (2). The present investigation shows that after acclimatization to high altitude, the increase in submaximal after PV expansion is brought about by an enhancement of the chronotropic response while stroke volume is maintained.

In contrast to our results, a small expansion of PV (220 ml) has been reported to increase O2 max by 9% in subjects acclimatized for 1 wk to 4,350 m, followed by 10–12 days at a simulated altitude of 6,000 m (40). Although the subjects studied by Robach et al. (40) exhibited a 26% reduction in PV after 10–12 days at 6,000 m (compared with sea level), it does not seem plausible that the small PV expansion induced in their study by the administration of 220 ml of 6% hydroxyethyl starch could have accounted for the enhancement of O2 max on the basis of an elevation of the circulatory volume as they argued. Given the tight coupling that exists between O2 supply and O2 at maximal exercise, particularly in hypoxia (11, 12, 39), and/or leg blood flow would have had to be enhanced by >9% (due to the hemodilutional effect of PV expansion) to achieve a 9% higher O2 delivery at peak exercise. Robach et al. did not measure, however, nor muscular O2 delivery, and thus they could not explain the mechanisms by which O2 max was improved under their experimental conditions. Part of the discrepancy between our findings and those of Robach et al. may be ascribed to the fact that the experiments of Robach et al. were carried out after 3 wk of hypoxia exposure, a period during which BV is likely lower than after 9 wk of acclimatization.

In agreement with our results, Young et al. (54) did not find any significant effect of 700 ml of autologous erythrocyte infusion, performed 24 h before the ascent to Pike’s Peak (4,300 m), on the O2 max response 24 h and 9 days after the ascension. The fact that O2 max was not increased with the erythrocyte transfusion in the experiments of Young et al. together with the observation made in the present investigation of no deterioration of O2 max with hypervolemic hemodilution indicates that different mechanisms limit O2 max during exercise in acute and chronic hypoxia (11, 12).

Other investigations on the effects of PV expansion on max have been limited to sea level conditions. In the present study, sea level-equivalent oxygenation was reproduced by allowing the subjects to breath a hyperoxic (FIO2 = 0.55) gas mixture at altitude. This resulted in similar increases of in both normal and expanded PV conditions. Moreover, with hyperoxia max at altitude increased to the same values as at sea level (11, 12). Had the reduction in max been caused by hypovolemia and lowered preload, hyperoxia would not have led to such increases. In general, previous investigations have reported no increase of max during exercise at sea level with PV expansion (16, 26, 41, 49, 51). Robinson et al. (41) and Ekblom et al. (16) did not report any significant change in max after an autologous transfusion of 0.8–1.2 liters of blood. Kanstrup and Ekblom (26) observed a nonstatistically significant increase of max of 2 l/min after inducing a PV expansion of 700 ml. In contrast, two other studies have reported an increase of max with blood transfusion (49) and PV expansion (51). Thomson et al. (49) found an increase of 2.5 l/min after an autologous blood transfusion of 1 liter in four subjects. However, in the later study, at peak exercise was estimated from the submaximal relationship between and O2, which may raise some concerns about the validity of these findings (49). PV expansion with 500 ml of 6% dextran resulted in 3% greater max, measured with the acetylene rebreathing technique in nine elite cyclists (51). Several factors have been proposed to account for these discrepancies between studies. It has been suggested that subjects with a lower degree of fitness (lower O2 max) and lower BV before expansion are more prone to experience an elevation of max with PV expansion (29, 51). Despite our subjects having O2 max values that were ~20% higher than those reported for the general Danish population of similar age (3), but 20–30% lower than elite endurance athletes (44, 51), no enhancement of was observed with PV expansion in any condition.

Why did max not increase with PV expansion at altitude? PV expansion could fail to increase preload if left ventricle distension is limited by other factors such as some degree of pericardial constraint (47) and increased right ventricular volume due to high afterload on the right side of the heart, caused by pulmonary hypertension (48). Even at higher altitudes (and degree of hypoxia) than in the present expedition, only a mild (not quantified) right ventricle dilation has been reported (48), which was not accompanied by any sign of right heart failure. If present at all, any sign of right heart failure should have been really mild and transitory, because hyperoxia at altitude restored sea level max in both volemic conditions. Thus it appears unlikely that these changes could really occur in healthy subjects during acclimatization to 5,260 m; indeed, severe damage should be inflicted to the right ventricle to cause right cardiac failure (19).

Other factors such as increased afterload and attenuated myocardial contractility could have been responsible for the low max after altitude acclimatization. Chronic hypoxia may decrease myocardial contractility because of an alteration of intracellular Ca2+ concentration ([Ca2+]i) homeostasis, such that the magnitude of the [Ca2+]i transient in response to several inotropic factors is attenuated (33, 34, 46). Chronic hypoxia (FIO2 = 0.10) is associated with reduced expression of and Ca2+ uptake by sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA), reduced release of Ca2+ via ryanodine receptors, and reduced extrusion of Ca2+ by Na+/Ca2+ exchange in rats (32). Although we cannot rule out a reduced myocardial contractility after altitude acclimatization, the fact that our subjects were able to reach at altitude the sea level max just by breathing a hyperoxic gas at altitude (10, 13) argues against any important impairment of myocardial contractility elicited by structural changes in the cardiomyocytes. Moreover, myocardial contractility appears to be preserved in humans submitted to higher levels of chronic hypoxia (37).

The aerobic demand of the heart may be estimated by calculating the double product (the product of heart rate times systolic arterial pressure) (25, 28). Maximal exercise double product has been reported to be lower in hypoxia than in normoxia (9), moderate hyperoxia (8), or pure hyperoxia (48). The present investigation shows that the double product is significantly increased by PV expansion during maximal exercise in chronic hypoxia. The latter implies that at the moment of exhaustion in the euvolemic condition, the heart was still able to further increase its work, despite the fact that with hypervolemia PaO2 was similar while CaO2 was lower than during euvolemia. Perhaps after PV expansion, the work efficiency of the heart improved because of additional recruitment of the Frank-Starling mechanism. However, the lack of enhancement of stroke volume at maximal exercise with PV expansion argues against this possibility in our experimental conditions. Alternatively, the increase of maximal double product with PV expansion could have been brought about by rising coronary blood flow and hence coronary O2 delivery.

Blood viscosity increases exponentially with hematocrit, and consequently afterload may be greater after altitude acclimatization, impairing systolic emptying. PV expansion was, however, accompanied by 19% hemodilution without any significant effect on mean arterial pressure, suggesting that the level of hemoconcentration reached after altitude acclimatization could have exerted only a marginal influence on the afterload during maximal exercise. Furthermore, when hypoxia was eliminated acutely in the euvolemic as well as in the hypervolemic conditions by breathing 55% O2, the maximal heart rate, stroke volume, and observed at altitude were similar to those obtained subsequently in the same subjects at sea level (11). The increase in with hyperoxia at altitude occurred despite mean arterial pressure remaining at the same level, i.e., with the same afterload, a greater max was achieved just by improving oxygenation. Had afterload been the limiting factor of max at altitude, such an increase should not have been seen.

Effect of hemodilution on leg blood flow and vascular conductance. PV expansion caused hemodilution, but maximal leg O2 delivery and leg O2 were maintained at the euvolemic level. The latter was possible because, after PV expansion, maximal leg blood flow at altitude tends to be higher, whereas the perfusion to vascular beds apart from the legs is reduced. These changes are similar but of lower magnitude than observed in the same subjects with a greater level of hemodilution (13). Our results suggest that the elevation of leg blood flow with hypervolemic hemodilution was brought about by increasing leg vascular conductance, as observed during isovolemic hemodilution (13), inasmuch as perfusion pressure was not altered by hypervolemia. The increase of maximal leg vascular conductance occurred despite similar arterial catecholamine concentrations in both conditions, suggesting comparable sympathetic vasoconstrictor tone. However, for a given norepinephrine clearance, the arterial norepinephrine concentration may remain unchanged and leg sympathetic tone decreased if norepinephrine spillover is reduced across the legs and at the same time increased in other vascular beds. Maximal leg vascular conductance could have also been increased through enhanced vasodilating activity, probably of metabolic origin (24, 43).

Effect of hemodilution on O2 transport and utilization. Previous investigations in which [Hb] was isovolemically reduced in polycythemic highlanders (52) or lowlanders acclimatized to altitude (13) showed no reduction of maximal exercise capacity or O2 max. The current study also demonstrates that maximal exercise capacity and O2 max are maintained after hypervolemic hemodilution. Borst et al. (7) reported marked improvements in pulmonary hemodynamics and gas exchange with hemodilution in patients with severe chronic obstructive pulmonary disease. In contrast, this study shows that pulmonary ventilation, gas exchange, and acid-base balance are essentially not affected by hypervolemic hemodilution in healthy humans exercising at altitude.

Potential limitations. The fact that hypervolemic exercise was preceded by another experiment (isovolemic hemodilution) (13) might have influenced some of the results here reported. However, the 90-min resting period that followed the isovolemic hemodilution experiments should have minimized their impact on the subsequent hypervolemic experiments. In fact, the subjects were able to reach sea level max during the hypervolemic conditions with hyperoxia. The population here studied has some particularities that should be taken into consideration. First, our subjects had an enhanced O2 max compared with young adults of the general Danish population (3). It has been suggested that because trained subjects have increased BV, they may be less responsive to PV expansion during exercise at sea level (51). Despite this fact, our subjects were quite sensitive to PV expansion as reflected by the substantial elevation of resting and submaximal exercise after PV expansion at altitude. Thus it seems that our findings cannot be attributed to a high O2 max of our subjects. Second, the study population included three women; this fact could have caused some heterogeneity in the ventilatory and cardiovascular responses to altitude acclimatization. However, our data and that of others (6, 17, 18, 30, 31, 53) show that the acclimatization process to altitude is rather similar in male and females, with the exception of the known increased ventilation that women have at both sea level and altitude. The latter has a minor impact on pulmonary gas exchange in hypoxia, i.e., the SaO2 and PaO2 are almost the same in males and females subjected to chronic hypoxia (6, 17, 18, 30, 31, 53). Third, the high between-subject variability might have increased the risk for a type II error due to insufficient statistical power.

In summary, this study has shown that a reduced circulating BV is not a primary factor in explaining the reduction in max observed after altitude acclimatization. Substantial acute PV expansion by ~1 liter at altitude has no effect on max, O2 max, or exercise capacity in well-acclimatized lowlanders. Overall, leg blood flow in the working legs was enhanced after PV expansion and compensated entirely for the dilutional decrease in [Hb] resulting in similar O2 delivery and leg O2 at maximal exercise in both conditions. Despite maximal systemic O2 transport being reduced because of 19% hemodilution, O2 max was maintained by greater systemic O2 extraction after PV expansion. Under conditions of both normal and increased BV, when the sea level environment was reproduced by the utilization of hyperoxia at altitude, max and work rate increased to values similar to sea level. This further supports our finding that max at altitude is not limited by a lower circulating volume or increased blood viscosity.


    GRANTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
This study was supported by a grant from The Danish National Research Foundation (504-14) and by the Carlsberg Foundation.


    ACKNOWLEDGMENTS
 
We give special thanks to Harrieth Wagner, Carsten Nielsen, Karin Hansen, and Birgitte Jessen for excellent technical assistance. We also acknowledge the Academia de Ciencias de Bolivia and especially Dr. Carlos Aguirre for all the help and support in setting our expeditionary laboratory at the heights of Mt. Chacaltaya. The help and support provided by Dr. Mauricio Araoz and Dr. Hilde Spielvogel are also greatly acknowledged.

During this study, J. A. L. Calbet was on leave from the Department of Physical Education at the University of Las Palmas de Gran Canaria.


    FOOTNOTES
 

Address for reprint requests and other correspondence: J. A. L. Calbet, Departamento de Educación Física, Campus Universitario de Tafira, 35017 Las Palmas de Gran Canaria, 35010 Canary Islands, Spain (E-mail: lopezcalbet{at}terra.es).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. Alexander JK and Grover RF. Mechanism of reduced cardiac stroke volume at high altitude. Clin Cardiol 6: 301–303, 1983.
  2. Alexander JK, Hartley LH, Modelski M, and Grover RF. Reduction of stroke volume during exercise in man following ascent to 3,100 m altitude. J Appl Physiol 23: 849–858, 1967.
  3. Andersen LB and Haraldsdottir J. Maximal oxygen uptake, maximal voluntary isometric contraction and physical activity in young Danish adults. Eur J Appl Physiol Occup Physiol 67: 315–320, 1993.
  4. Andersen P and Saltin B. Maximal perfusion of skeletal muscle in man. J Physiol 366: 233–249, 1985.
  5. Balke B, Grillo GP, Konecci EB, and Luft UC. Work capacity after blood donation. J Appl Physiol 7: 231–238, 1954.
  6. Bhaumik G, Sharma RP, Dass D, Lama H, Chauhan SK, Verma SS, Selvamurthy W, and Banerjee PK. Hypoxic ventilatory response changes of men and women 6 to 7 days after climbing from 2100 m to 4350 m altitude and after descent. High Alt Med Biol 4: 341–348, 2003.
  7. Borst MM, Leschke M, Konig U, and Worth H. Repetitive hemodilution in chronic obstructive pulmonary disease and pulmonary hypertension: effects on pulmonary hemodynamics, gas exchange, and exercise capacity. Respiration 66: 225–232, 1999.
  8. Boushel R, Calbet JA, Radegran G, Sondergaard H, Wagner PD, and Saltin B. Parasympathetic neural activity accounts for the lowering of exercise heart rate at high altitude. Circulation 104: 1785–1791, 2001.
  9. Boutellier U, Deriaz O, di Prampero PE, and Cerretelli P. Aerobic performance at altitude: effects of acclimatization and hematocrit with reference to training. Int J Sports Med 11, Suppl 1: S21–S26, 1990.
  10. Calbet JA. Chronic hypoxia increases blood pressure and noradrenaline spillover in healthy humans. J Physiol 551: 379–386, 2003.
  11. Calbet JA, Boushel R, Radegran G, Sondergaard H, Wagner PD, and Saltin B. Determinants of maximal oxygen uptake in severe acute hypoxia. Am J Physiol Regul Integr Comp Physiol 284: R291–R303, 2003.
  12. Calbet JA, Boushel R, Radegran G, Sondergaard H, Wagner PD, and Saltin B. Why is O2 max after altitude acclimatization still reduced despite normalization of arterial O2 content? Am J Physiol Regul Integr Comp Physiol 284: R304–R316, 2003.
  13. Calbet JA, Radegran G, Boushel R, Sondergaard H, Saltin B, and Wagner PD. Effect of blood haemoglobin concentration on VO2max and cardiovascular function in lowlanders acclimatised to 5,260 m. J Physiol 545: 715–728, 2002.
  14. Calbet JAL, Jensen-Urstad M, van Hall G, Holmberg HC, Rosdahl H, and Saltin B. Maximal muscular vascular conductances during whole body upright exercise in humans. J Physiol 558: 319–331, 2004; 10.1113/jphysiol.2003.059287.
  15. Convertino VA. Cardiovascular consequences of bed rest: effect on maximal oxygen uptake. Med Sci Sports Exerc 29: 191–196, 1997.
  16. Ekblom B, Wilson G, and Astrand PO. Central circulation during exercise after venesection and reinfusion of red blood cells. J Appl Physiol 40: 379–383, 1976.
  17. Fulco CS, Rock PB, and Cymerman A. Maximal and submaximal exercise performance at altitude. Aviat Space Environ Med 69: 793–801, 1998.
  18. Fulco CS, Rock PB, Muza SR, Lammi E, Braun B, Cymerman A, Moore LG, and Lewis SF. Gender alters impact of hypobaric hypoxia on adductor pollicis muscle performance. J Appl Physiol 91: 100–108, 2001.
  19. Goldstein JA. Pathophysiology and management of right heart ischemia. J Am Coll Cardiol 40: 841–853, 2002.
  20. Gonzalez-Alonso J and Calbet JA. Reductions in systemic and skeletal muscle blood flow and oxygen delivery limit maximal aerobic capacity in humans. Circulation 107: 824–830, 2003.
  21. Haller M, Akbulut C, Brechtelsbauer H, Fett W, Briegel J, Finsterer U, and Peter K. Determination of plasma volume with indocyanine green in man. Life Sci 53: 1597–1604, 1993.
  22. Hallman H, Farnebo LO, Hamberger B, and Johnsson G. A sensitive method for the determination of plasma catecholamines using liquid chromatography with electrochemical detection. Life Sci 23: 1049–1052, 1978.
  23. Hansen J and Sander M. Sympathetic neural overactivity in healthy humans after prolonged exposure to hypobaric hypoxia. J Physiol 546: 921–929, 2003.
  24. Hansen J, Sander M, and Thomas GD. Metabolic modulation of sympathetic vasoconstriction in exercising skeletal muscle. Acta Physiol Scand 168: 489–503, 2000.
  25. Jorgensen CR, Wang K, Wang Y, Gobel FL, Nelson RR, and Taylor H. Effect of propranolol on myocardial oxygen consumption and its hemodynamic correlates during upright exercise. Circulation 48: 1173–1182, 1973.
  26. Kanstrup IL and Ekblom B. Acute hypervolemia, cardiac performance, and aerobic power during exercise. J Appl Physiol 52: 1186–1191, 1982.
  27. Kappagoda CT, Linden RJ, and Snow HM. A reflex increase in heart rate from distension of the junction between the superior vena cava and the right atrium. J Physiol 220: 177–197, 1972.
  28. Kitamura K, Jorgensen CR, Gobel FL, Taylor HL, and Wang Y. Hemodynamic correlates of myocardial oxygen consumption during upright exercise. J Appl Physiol 32: 516–522, 1972.
  29. Krip B, Gledhill N, Jamnik V, and Warburton D. Effect of alterations in blood volume on cardiac function during maximal exercise. Med Sci Sports Exerc 29: 1469–1476, 1997.
  30. Loeppky JA, Scotto P, Charlton GC, Gates L, Icenogle M, and Roach RC. Ventilation is greater in women than men, but the increase during acute altitude hypoxia is the same. Respir Physiol 125: 225–237, 2001.
  31. Muza SR, Rock PB, Fulco CS, Zamudio S, Braun B, Cymerman A, Butterfield GE, and Moore LG. Women at altitude: ventilatory acclimatization at 4,300 m. J Appl Physiol 91: 1791–1799, 2001.
  32. Pei JM, Kravtsov GM, Wu S, Das R, Fung ML, and Wong TM. Calcium homeostasis in rat cardiomyocytes during chronic hypoxia: a time course study. Am J Physiol Cell Physiol 285: C1420–C1428, 2003.
  33. Pei JM, Yu XC, Fung ML, Zhou JJ, Cheung CS, Wong NS, Leung MP, and Wong TM. Impaired Gs{alpha} and adenylyl cyclase cause {beta}-adrenoceptor desensitization in chronically hypoxic rat hearts. Am J Physiol Cell Physiol 279: C1455–C1463, 2000.
  34. Pei JM, Zhou JJ, Bian JS, Yu XC, Fung ML, and Wong TM. Impaired [Ca2+]i and pHi responses to {kappa}-opioid receptor stimulation in the heart of chronically hypoxic rats. Am J Physiol Cell Physiol 279: C1483–C1494, 2000.
  35. Pugh LGCE. Blood volume and hemoglobin concentration at altitudes above 18,000 ft (5,500 m). J Physiol 170: 344–354, 1964.
  36. Pugh LGCE. Cardiac output in muscular exercise at 5,800 m (19,000 ft). J Appl Physiol 19: 441–447, 1964.
  37. Reeves JT, Groves BM, Sutton JR, Wagner PD, Cymerman A, Malconian MK, Rock PB, Young PM, and Houston CS. Operation Everest II: preservation of cardiac function at extreme altitude. J Appl Physiol 63: 531–539, 1987.
  38. Reynafarje C, Lozano R, and Valdivieso J. The polycythemia of high altitudes: iron metabolism and related aspects. Blood 14: 433–455, 1959.
  39. Roach RC, Koskolou MD, Calbet JA, and Saltin B. Arterial O2 content and tension in regulation of cardiac output and leg blood flow during exercise in humans. Am J Physiol Heart Circ Physiol 276: H438–H445, 1999.
  40. Robach P, Dechaux M, Jarrot S, Vaysse J, Schneider JC, Mason NP, Herry JP, Gardette B, and Richalet JP. Operation Everest III: role of plasma volume expansion on O2 max during prolonged high-altitude exposure. J Appl Physiol 89: 29–37, 2000.
  41. Robinson BF, Epstein SE, Kahler RL, and Braunwald E. Circulatory effects of acute expansion of blood volume: studies during maximal exercise and at rest. Circ Res 29: 26–32, 1966.
  42. Saltin B. Circulatory response to submaximal and maximal exercise after thermal dehydration. J Appl Physiol 19: 1125–1132, 1964.
  43. Saltin B, Radegran G, Koskolou MD, and Roach RC. Skeletal muscle blood flow in humans and its regulation during exercise. Acta Physiol Scand 162: 421–436, 1998.
  44. Sawka MN, Convertino VA, Eichner ER, Schnieder SM, and Young AJ. Blood volume: importance and adaptations to exercise training, environmental stresses, and trauma/sickness. Med Sci Sports Exerc 32: 332–348, 2000.
  45. Severinghaus JW. Simple, accurate equations for human blood O2 dissociation computations. J Appl Physiol 46: 599–602, 1979.
  46. Shan J, Yu XC, Fung ML, and Wong TM. Attenuated "cross talk" between {kappa}-opioid receptors and {beta}-adrenoceptors in the heart of chronically hypoxic rats. Pflügers Arch 444: 126–132, 2002.
  47. Stray-Gundersen J, Musch TI, Haidet GC, Swain DP, Ordway GA, and Mitchell JH. The effect of pericardiectomy on maximal oxygen consumption and maximal cardiac output in untrained dogs. Circ Res 58: 523–530, 1986.
  48. Suarez J, Alexander JK, and Houston CS. Enhanced left ventricular systolic performance at high altitude during Operation Everest II. Am J Cardiol 60: 137–142, 1987.
  49. Thomson JM, Stone JA, Ginsburg AD, and Hamilton P. O2 transport during exercise following blood reinfusion. J Appl Physiol 53: 1213–1219, 1982.
  50. Wagner PD. New ideas on limitations to VO2max. Exerc Sport Sci Rev 28: 10–14, 2000.
  51. Warburton DE, Gledhill N, Jamnik VK, Krip B, and Card N. Induced hypervolemia, cardiac function, VO2max, and performance of elite cyclists. Med Sci Sports Exerc 31: 800–808, 1999.
  52. Winslow RM, Monge CC, Brown EG, Klein HG, Sarnquist F, Winslow NJ, and McKneally SS. Effects of hemodilution on O2 transport in high-altitude polycythemia. J Appl Physiol 59: 1495–1502, 1985.
  53. Wood S, Norboo T, Lilly M, Yoneda K, and Eldridge M. Cardiopulmonary function in high altitude residents of Ladakh. High Alt Med Biol 4: 445–454, 2003.
  54. Young AJ, Sawka MN, Muza SR, Boushel R, Lyons T, Rock PB, Freund BJ, Waters R, Cymerman A, Pandolf KB, and Valeri CR. Effects of erythrocyte infusion on O2 max at high altitude. J Appl Physiol 81: 252–259, 1996.



This article has been cited by other articles:


Home page
J. Physiol.Home page
C. Lundby, R. Boushel, P. Robach, K. Moller, B. Saltin, and J. A. L. Calbet
During hypoxic exercise some vasoconstriction is needed to match O2 delivery with O2 demand at the microcirculatory level
J. Physiol., January 1, 2008; 586(1): 123 - 130.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
N. J. A. Berger, I. T. Campbell, D. P. Wilkerson, and A. M. Jones
Influence of acute plasma volume expansion on VO2 kinetics, VO2peak, and performance during high-intensity cycle exercise
J Appl Physiol, September 1, 2006; 101(3): 707 - 714.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. K. Stickland, R. C. Welsh, M. J. Haykowsky, S. R. Petersen, W. D. Anderson, D. A. Taylor, M. Bouffard, and R. L. Jones
Effect of acute increases in pulmonary vascular pressures on exercise pulmonary gas exchange
J Appl Physiol, June 1, 2006; 100(6): 1910 - 1917.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. A L Calbet, R. Boushel, and C. Lundby
Comment on Point:Counterpoint "Positive effects of intermittent hypoxia (live high:train low) on exercise performance are/are not mediated primarily by augmented red cell volume"
J Appl Physiol, February 1, 2006; 100(2): 749 - 749.
[Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. D. Noakes, J. A. L. Calbet, R. Boushel, H. Sondergaard, G. Radegran, P. D. Wagner, and B. Saltin
Central regulation of skeletal muscle recruitment explains the reduced maximal cardiac output during exercise in hypoxia
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2004; 287(4): R996 - R1002.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available